iTeos Therapeutics, Inc.
ITOS
$7.77
$0.273.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.82% | 3.63% | -536.34% | 81.35% | -25.09% |
| Total Depreciation and Amortization | 0.62% | 6.62% | -2.58% | 1.97% | 33.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 973.87% | -91.99% | 15.14% | 16.56% | -9.69% |
| Change in Net Operating Assets | -109.70% | 2,858.50% | 105.05% | -3,370.71% | -91.43% |
| Cash from Operations | -714.23% | 114.72% | -10.09% | -4.71% | -135.38% |
| Capital Expenditure | 33.55% | -61.70% | 78.73% | 53.23% | 32.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 247.11% | 115.07% | -645.19% | 124.42% | -209.06% |
| Cash from Investing | 250.24% | 114.88% | -660.53% | 123.45% | -213.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -88.32% | 495.65% | -99.96% | 556,154.55% | -92.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 102.25% | -- | -- | -- |
| Cash from Financing | -88.77% | 164.48% | -100.36% | 556,154.55% | -92.83% |
| Foreign Exchange rate Adjustments | 144.91% | -152.82% | 769.55% | 88.68% | -143.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.54% | 114.43% | -221.89% | 199.95% | -322.17% |